Your browser doesn't support javascript.
loading
Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy.
Saad, Fred; Latour, Mathieu; Lattouf, Jean-Baptiste; Widmer, Hugues; Zorn, Kevin C; Mes-Masson, Anne-Marie; Ouellet, Veronique; Saad, Genevieve; Prakash, Amol; Choudhury, Sibgat; Han, Gang; Karakiewicz, Pierre; Richie, Jerome P.
Afiliación
  • Saad F; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department
  • Latour M; Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Quebec, Canada.
  • Lattouf JB; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada.
  • Widmer H; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada.
  • Zorn KC; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada.
  • Mes-Masson AM; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Ouellet V; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada.
  • Saad G; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada.
  • Prakash A; Metamark Genetics, Inc., Cambridge, Massachusetts.
  • Choudhury S; Metamark Genetics, Inc., Cambridge, Massachusetts.
  • Han G; Metamark Genetics, Inc., Cambridge, Massachusetts; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas.
  • Karakiewicz P; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Richie JP; Metamark Genetics, Inc., Cambridge, Massachusetts.
J Urol ; 197(4): 1034-1040, 2017 04.
Article en En | MEDLINE | ID: mdl-27725152
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Prostatectomía / Neoplasias de la Próstata / Proteómica / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Prostatectomía / Neoplasias de la Próstata / Proteómica / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos